In this issue

Articles in the same Issue

1. Frontmatter
2. In this issue
3. News
4. News from the European Foundation for Clinical Nanomedicine (CLINAM)
5. What’s up in nanomedicine?
6. Special Section Nanosafety
7. Guest Editorial
8. Sizing up the safety of nanomaterials
9. Essay
10. Keeping it small: towards a molecular definition of nanotoxicology
11. Reviews
12. The bio-corona and its impact on nanomaterial toxicity
13. In vitro-ex vivo model systems for nanosafety assessment
14. Meeting Report
15. Nanosafety forum for young scientists: a meeting report
16. Short Communication
17. Nanomedicines in the European translational process
18. Special Section CARPA Part 2
19. Guest Editorial
20. Complement activation-related pseudoallergy: an innate response to nanomedicines acting as pseudo-viruses
21. Reviews
22. Exosomes: potential model for complement-stealth delivery systems
23. Lessons learned from the porcine CARPA model: constant and variable responses to different nanomedicines and administration protocols
24. Mini Review
25. Blood cell changes in complement activation-related pseudoallergy
26. Short Communications
27. Membrane attack complex formation on a supported lipid bilayer: initial steps towards a CARPA predictor nanodevice
28. Paradoxical rise of hemolytic complement in the blood of mice during zymosan- and liposome-induced CARPA: a pilot study
29. Commentary
30. Insidious pathogen-mimicking properties of nanoparticles in triggering the lectin pathway of the complement system